IL218119A - Antibodies for detecting integrin complex in ffpe material - Google Patents
Antibodies for detecting integrin complex in ffpe materialInfo
- Publication number
- IL218119A IL218119A IL218119A IL21811912A IL218119A IL 218119 A IL218119 A IL 218119A IL 218119 A IL218119 A IL 218119A IL 21811912 A IL21811912 A IL 21811912A IL 218119 A IL218119 A IL 218119A
- Authority
- IL
- Israel
- Prior art keywords
- antibodies
- detection
- ffpe material
- integrin complexes
- integrin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09010666 | 2009-08-19 | ||
| PCT/EP2010/004313 WO2011020529A2 (fr) | 2009-08-19 | 2010-07-15 | Anticorps pour la détection de complexes d'intégrine dans une matière ffpe |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL218119A0 IL218119A0 (en) | 2012-04-30 |
| IL218119A true IL218119A (en) | 2015-08-31 |
Family
ID=42813245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL218119A IL218119A (en) | 2009-08-19 | 2012-02-14 | Antibodies for detecting integrin complex in ffpe material |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8420348B2 (fr) |
| EP (1) | EP2467401B1 (fr) |
| JP (1) | JP5734978B2 (fr) |
| KR (1) | KR101606236B1 (fr) |
| CN (1) | CN102597001B (fr) |
| AU (1) | AU2010285265B2 (fr) |
| BR (1) | BR112012003686B1 (fr) |
| CA (1) | CA2771441C (fr) |
| DK (1) | DK2467401T3 (fr) |
| EA (1) | EA032728B1 (fr) |
| ES (1) | ES2622487T3 (fr) |
| HK (1) | HK1173455A1 (fr) |
| IL (1) | IL218119A (fr) |
| MX (1) | MX2012001741A (fr) |
| PT (1) | PT2467401T (fr) |
| SG (1) | SG178348A1 (fr) |
| WO (1) | WO2011020529A2 (fr) |
| ZA (1) | ZA201201990B (fr) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2733492T3 (en) | 2008-08-05 | 2016-04-25 | Toray Industries | Method for detection of cancer |
| KR101667319B1 (ko) | 2008-08-05 | 2016-10-18 | 도레이 카부시키가이샤 | 암의 치료 및 예방용 의약 조성물 |
| RU2603742C2 (ru) | 2010-02-04 | 2016-11-27 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики рака |
| CA2788720C (fr) | 2010-02-04 | 2019-08-20 | Takayoshi Ido | Agent pharmaceutique destine au traitement et/ou a la prevention du cancer |
| KR101842893B1 (ko) | 2010-02-04 | 2018-03-28 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
| PT2672994T (pt) | 2011-02-11 | 2018-10-22 | Merck Patent Gmbh | Anticorpo anti-integrina alfa-v para o tratamento do cancro da próstata |
| DK2740793T3 (en) | 2011-08-04 | 2018-01-22 | Toray Industries | PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND / OR PREVENTION |
| PT2740489T (pt) | 2011-08-04 | 2017-01-10 | Toray Industries | Composição farmacêutica para o tratamento e/ou a prevenção do cancro pancreático |
| PL2740795T3 (pl) | 2011-08-04 | 2017-04-28 | Toray Industries, Inc. | Kompozycja lekowa do leczenia nowotworu i/lub zapobiegania nowotworowi |
| ES2629061T3 (es) | 2011-08-04 | 2017-08-07 | Toray Industries, Inc. | Método para la detección de cáncer pancreático |
| DK2740794T3 (en) | 2011-08-04 | 2018-06-14 | Toray Industries | PHARMACEUTICAL COMPOSITION FOR TREATMENT AND / OR CANCER PREVENTION |
| PT2740798T (pt) | 2011-08-04 | 2017-03-13 | Toray Industries | Composição de fármaco para o tratamento e/ou a prevenção de cancro |
| EP2740796B1 (fr) | 2011-08-04 | 2017-05-17 | Toray Industries, Inc. | Composition pharmaceutique destinée à traiter ou à prévenir le cancer |
| ES2643397T3 (es) * | 2011-08-17 | 2017-11-22 | The Regents Of The University Of California | Anticuerpos que se unen con integrina alfa-v beta-8 |
| PT2818481T (pt) | 2012-02-21 | 2019-10-25 | Toray Industries | Composição farmacêutica para tratamento e/ou prevenção de cancro |
| ES2739612T3 (es) | 2012-02-21 | 2020-02-03 | Toray Industries | Composición farmacéutica para el tratamiento de cáncer |
| CN104114583B (zh) | 2012-02-21 | 2019-11-19 | 东丽株式会社 | 癌的治疗和/或预防用药物组合物 |
| ES2643241T3 (es) | 2012-02-21 | 2017-11-21 | Toray Industries, Inc. | Composición medicinal para tratar y/o prevenir el cáncer |
| AU2013241043B2 (en) | 2012-03-30 | 2017-11-09 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of gall bladder cancer |
| ES2656620T3 (es) | 2012-03-30 | 2018-02-27 | Toray Industries, Inc. | Composición farmacéutica para el tratamiento y/o la prevención del cáncer de hígado |
| ES2769831T3 (es) | 2012-07-19 | 2020-06-29 | Toray Industries | Método para detectar cáncer |
| PL2876446T3 (pl) | 2012-07-19 | 2019-06-28 | Toray Industries, Inc. | Sposób wykrywania nowotworu |
| TWI646230B (zh) | 2013-08-05 | 2019-01-01 | 扭轉生物科技有限公司 | 重新合成之基因庫 |
| WO2015020212A1 (fr) * | 2013-08-09 | 2015-02-12 | 東レ株式会社 | Composition pharmaceutique pour le traitement et/ou la prévention du cancer |
| AU2015218355B2 (en) | 2014-02-14 | 2019-09-12 | Arkansas Children's Hospital Research Institute, Inc. | Acetaminophen protein adducts and methods of use thereof |
| WO2016026956A1 (fr) * | 2014-08-22 | 2016-02-25 | Baxalta GmbH | Détection de contaminations cho-mif |
| EP3009147A1 (fr) | 2014-10-16 | 2016-04-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Procédé de traitement de glioblastome résistant |
| WO2016090163A2 (fr) * | 2014-12-03 | 2016-06-09 | Board Of Trustees Of The University Of Arkansas | Anticorps anti-acétaminophène et produits d'addition acétaminophène-protéine |
| CA2975852A1 (fr) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Procedes et dispositifs pour assemblage de novo d'acide oligonucleique |
| US9981239B2 (en) | 2015-04-21 | 2018-05-29 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
| CA2998169A1 (fr) | 2015-09-18 | 2017-03-23 | Twist Bioscience Corporation | Banques de variants d'acides oligonucleiques et synthese de ceux-ci |
| CN108698012A (zh) | 2015-09-22 | 2018-10-23 | 特韦斯特生物科学公司 | 用于核酸合成的柔性基底 |
| WO2017182834A1 (fr) | 2016-04-19 | 2017-10-26 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Nouvelle méthode de traitement d'un glioblastome résistant |
| US10417457B2 (en) | 2016-09-21 | 2019-09-17 | Twist Bioscience Corporation | Nucleic acid based data storage |
| US11550939B2 (en) | 2017-02-22 | 2023-01-10 | Twist Bioscience Corporation | Nucleic acid based data storage using enzymatic bioencryption |
| WO2018231864A1 (fr) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Méthodes d'assemblage d'acides nucléiques continus |
| EP3638782A4 (fr) | 2017-06-12 | 2021-03-17 | Twist Bioscience Corporation | Méthodes d'assemblage d'acides nucléiques sans joint |
| CN111566125A (zh) | 2017-09-11 | 2020-08-21 | 特韦斯特生物科学公司 | Gpcr结合蛋白及其合成 |
| KR20240024357A (ko) | 2017-10-20 | 2024-02-23 | 트위스트 바이오사이언스 코포레이션 | 폴리뉴클레오타이드 합성을 위한 가열된 나노웰 |
| US11820823B2 (en) * | 2017-10-27 | 2023-11-21 | Kite Pharma, Inc. | T cell receptor antigen binding molecules and methods of use thereof |
| EP3814497A4 (fr) | 2018-05-18 | 2022-03-02 | Twist Bioscience Corporation | Polynucléotides, réactifs, et procédés d'hybridation d'acides nucléiques |
| TW202024131A (zh) * | 2018-09-07 | 2020-07-01 | 美商輝瑞大藥廠 | 抗-αvβ8抗體及組合物及其用途 |
| CA3123046A1 (fr) * | 2018-12-21 | 2020-06-25 | Board Of Regents, The University Of Texas System | Anticorps dicer phosphoryle et ses procedes d'utilisation |
| WO2020141608A1 (fr) * | 2019-01-04 | 2020-07-09 | 国立大学法人京都大学 | Méthode de test pour la rectocolite hémorragique et la cholangite sclérosante primitive |
| SG11202109283UA (en) | 2019-02-26 | 2021-09-29 | Twist Bioscience Corp | Variant nucleic acid libraries for antibody optimization |
| EP3987019A4 (fr) | 2019-06-21 | 2023-04-19 | Twist Bioscience Corporation | Assemblage de séquences d'acide nucléique basé sur des code-barres |
| EP3994167A4 (fr) * | 2019-07-02 | 2023-11-01 | Astute Medical, Inc. | Anticorps et dosages pour ccl14 |
| AU2020331301A1 (en) * | 2019-08-09 | 2022-02-24 | The Board Of Trustees Of The Leland Stanford Junior University | Therapeutic antibodies against osteopontin |
| US20210102195A1 (en) * | 2019-09-23 | 2021-04-08 | Twist Bioscience Corporation | Variant nucleic acid libraries for single domain antibodies |
| US11827709B2 (en) * | 2019-12-05 | 2023-11-28 | Seagen Inc. | Anti-AVB6 antibodies and antibody-drug conjugates |
| CN114907468B (zh) * | 2022-06-10 | 2023-05-23 | 东莞理工学院 | 一种仿刺参整合素多克隆抗体、抗原蛋白及其制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0341303A4 (fr) * | 1987-11-19 | 1990-06-27 | Scripps Clinic Res | Anticorps monoclonal utilise contre le recepteur d'adhesion a direction rgd de cellules endotheliales. |
| UA58482C2 (uk) * | 1994-06-08 | 2003-08-15 | Бьорінгер Інгельхайм Інтернаціональ Гмбх | Моноклональне антитіло vff-18 проти сd44v6 і його фрагменти |
| CN1194667A (zh) * | 1995-09-01 | 1998-09-30 | 拉莫特大学应用研究及工业发展有限公司 | 用于癌症治疗、预防和检测的蛋白质磷酸酶2C－PP2Cα－在肿瘤细胞中表达的操作和检测方法 |
| WO1999062933A2 (fr) | 1998-06-02 | 1999-12-09 | Affina Immuntechnik Gmbh | Peptides conçus de maniere rationnelle, leur production et leur utilisation |
| US7163681B2 (en) * | 2000-08-07 | 2007-01-16 | Centocor, Inc. | Anti-integrin antibodies, compositions, methods and uses |
| ATE368688T1 (de) | 2000-11-08 | 2007-08-15 | Fresenius Medical Care Affina | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen |
| US20030087250A1 (en) * | 2001-03-14 | 2003-05-08 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| CA2478239A1 (fr) | 2002-03-04 | 2003-09-18 | Medimmune, Inc. | Prevention ou traitement de cancer au moyen d'antagonistes de l'integrine alphavbeta3 combines a d'autres agents |
| EA011853B1 (ru) | 2002-03-13 | 2009-06-30 | Байоджен Айдек Ма Инк. | АНТИТЕЛА ПРОТИВ αβ |
| AU2003230929A1 (en) * | 2002-04-12 | 2003-10-27 | Raven Biotechnologies, Inc. | Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof |
| WO2004007530A2 (fr) | 2002-07-17 | 2004-01-22 | The Center For Blood Research, Inc. | Proteines modifiees stabilisees dans une conformation voulue et procedes de production de celles-ci |
| CN1444043A (zh) * | 2002-12-25 | 2003-09-24 | 帕弗瑞生物技术(北京)有限公司 | 一种个体化特异性免疫细胞功能测定方法 |
| SE0301087D0 (sv) * | 2003-04-14 | 2003-04-14 | Cartela Ab | New monoclonal antibody |
| US7429487B2 (en) | 2005-07-05 | 2008-09-30 | Epitomics, Inc. | Fusion partner for production of monoclonal rabbit antibodies |
| AU2006332216A1 (en) | 2005-12-30 | 2007-07-12 | Merck Patent Gmbh | Anti-IL-6 antibodies preventing the binding of IL-6 complexed with IL-6Ralpha to gp130 |
| WO2009010290A2 (fr) * | 2007-07-17 | 2009-01-22 | Merck Patent Gmbh | Anticorps hybrides modifiés dirigés contre l'intégrine alpha v |
-
2010
- 2010-07-15 EP EP10749593.9A patent/EP2467401B1/fr active Active
- 2010-07-15 CA CA2771441A patent/CA2771441C/fr active Active
- 2010-07-15 BR BR112012003686-6A patent/BR112012003686B1/pt active IP Right Grant
- 2010-07-15 DK DK10749593.9T patent/DK2467401T3/en active
- 2010-07-15 AU AU2010285265A patent/AU2010285265B2/en active Active
- 2010-07-15 US US13/390,791 patent/US8420348B2/en active Active
- 2010-07-15 KR KR1020127006938A patent/KR101606236B1/ko active IP Right Grant
- 2010-07-15 PT PT107495939T patent/PT2467401T/pt unknown
- 2010-07-15 CN CN201080036609.4A patent/CN102597001B/zh active Active
- 2010-07-15 WO PCT/EP2010/004313 patent/WO2011020529A2/fr active Application Filing
- 2010-07-15 JP JP2012525056A patent/JP5734978B2/ja active Active
- 2010-07-15 EA EA201200281A patent/EA032728B1/ru not_active IP Right Cessation
- 2010-07-15 ES ES10749593.9T patent/ES2622487T3/es active Active
- 2010-07-15 SG SG2012009254A patent/SG178348A1/en unknown
- 2010-07-15 MX MX2012001741A patent/MX2012001741A/es active IP Right Grant
-
2012
- 2012-02-14 IL IL218119A patent/IL218119A/en active IP Right Grant
- 2012-03-16 ZA ZA2012/01990A patent/ZA201201990B/en unknown
-
2013
- 2013-01-15 HK HK13100599.0A patent/HK1173455A1/xx unknown
- 2013-03-15 US US13/838,405 patent/US8993261B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2467401A2 (fr) | 2012-06-27 |
| ES2622487T3 (es) | 2017-07-06 |
| JP2013502205A (ja) | 2013-01-24 |
| WO2011020529A3 (fr) | 2011-06-16 |
| BR112012003686A2 (pt) | 2016-03-29 |
| JP5734978B2 (ja) | 2015-06-17 |
| EP2467401B1 (fr) | 2017-01-18 |
| AU2010285265A1 (en) | 2012-04-05 |
| HK1173455A1 (en) | 2013-05-16 |
| CA2771441A1 (fr) | 2011-02-24 |
| AU2010285265B2 (en) | 2015-05-21 |
| DK2467401T3 (en) | 2017-03-20 |
| US8420348B2 (en) | 2013-04-16 |
| EA201200281A1 (ru) | 2012-09-28 |
| PT2467401T (pt) | 2017-04-26 |
| SG178348A1 (en) | 2012-03-29 |
| AU2010285265A2 (en) | 2012-06-07 |
| US20130203079A1 (en) | 2013-08-08 |
| EA032728B1 (ru) | 2019-07-31 |
| CA2771441C (fr) | 2016-10-11 |
| KR101606236B1 (ko) | 2016-03-24 |
| WO2011020529A2 (fr) | 2011-02-24 |
| BR112012003686B1 (pt) | 2021-09-21 |
| CN102597001A (zh) | 2012-07-18 |
| CN102597001B (zh) | 2014-07-30 |
| WO2011020529A8 (fr) | 2011-04-21 |
| MX2012001741A (es) | 2012-03-21 |
| IL218119A0 (en) | 2012-04-30 |
| KR20120059556A (ko) | 2012-06-08 |
| US20120171699A1 (en) | 2012-07-05 |
| ZA201201990B (en) | 2012-11-28 |
| US8993261B2 (en) | 2015-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1173455A1 (en) | Antibodies for the detection of integrin complexes in ffpe material ffpe | |
| IL277166B (en) | Methods and materials for improving gastrointestinal activity | |
| IL244197A0 (en) | Antibodies against cd100 and methods of using them | |
| IL287311A (en) | Antibodies and processes for their preparation | |
| ZA201106983B (en) | Soluble "heavy-chain only" antibodies | |
| IL220390A (en) | Nano-active material for attachment and methods for attaching it | |
| ZA201107486B (en) | Anti-tnf-x antibodies and their uses | |
| EP2494062A4 (fr) | Anticorps anti-glp-1r et leurs utilisations | |
| IL226801B (en) | Material for radomes and process for preparation | |
| HK1209131A1 (en) | Anti-alpha2 integrin antibodies and their uses -2 | |
| GB201011574D0 (en) | PCBN material | |
| IL220536A0 (en) | Anti - bv8 antibodies and uses thereof | |
| HK1168653A1 (en) | A-fucosylation detection in antibodies a- | |
| EP2507263A4 (fr) | Anticorps anti-igf-ir et leurs utilisations | |
| IL214527A0 (en) | Anti-mst1r antibodies and uses thereof | |
| GB201009976D0 (en) | Material and process | |
| EP2419440A4 (fr) | Ligands peptidiques pour la clustérine et leurs utilisations | |
| EP2612893A4 (fr) | Matériau thermofluorescent et son procédé de production | |
| GB201011579D0 (en) | PCBN material | |
| PL392328A1 (pl) | 2-(Benzyloksykarbonyloamino)-6-izocyjanoheksaniany alkilowe oraz sposób ich wytwarzania | |
| PL390642A1 (pl) | Luminofor i sposób jego otrzymywania |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed |